MiR-19b is also associated with many neurological diseases, including Alzheimer’s disease and Parkinson’s disease, through its interactions with key targets such as Pten and Atxn1 [59–61]. Here, ATXN1 is linked to early-onset autosomal dominant Alzheimer disease.